Indeed, tumors treated by anti-CD47 antibody showed an increased antibody binding to tumor cells, whereas tumor binding antibody was less intensified in tumors treated with ET, indicating again that blocking FAO reduces CD47 expression. This evidence concerns the gene CD47 and neoplasm.